Quantcast
Home / Practice Areas / Business and Civil Practice / Pfizer must pay $142M over Neurontin marketing

Pfizer must pay $142M over Neurontin marketing

Drug maker Pfizer violated the Racketeer Influenced and Corrupt Organizations Act by engaging in a fraudulent marketing scheme promoting the epilepsy drug Neurontin for “off-label” uses, the 1st U.S. Circuit Court of Appeals has ruled in affirming judgment.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top